Based on NIH TACT 1 trial (Trial to Assess Chelation Therapy): 10 year, $31.6 million study by NIH in which 1,700 participants enrolled, all of whom were greater than 50 years old and who had suffered a heart attack, but without stent placement. Trial results…
• In patients with a history of heart attack: Modest reduction in cardiac events.
• In diabetics with a history of heart attack: 43% reduction in death from all causes in patients with chelation compared to those not receiving chelation.
• Reduction in stroke, heart attack, angina and coronary artery disease.